InvestorsHub Logo

dakota

01/14/15 12:07 AM

#3726 RE: dakota #3725

That article was published yesterday with the JUNO headlines. So the volume today probably came from those investors.

dayneyus

03/21/15 11:56 AM

#3769 RE: dakota #3725

I like the way the stock has performed sense Eastern Cap made their purchase. The following is a sample of their recent acquisitions, they seem to know and like undervalued Biotech.

http://biz.yahoo.com/t/89/8259.html

EASTERN CAPITAL LTD: Declared Holdings

Company/Relationship Reported Shares Ownership
Cyclacel Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:CYCC

(historical quotes, profile, other insiders) 9-Mar-15 5,607,143 Direct
Cytokinetics, Incorporated

Beneficial Owner (10% or more)
NasdaqCM:CYTK
(historical quotes, profile, other insiders) 25-Feb-14 2,883,845 Direct
iBio, Inc.
Beneficial Owner (10% or more)
NYSE MKT:IBIO

(historical quotes, profile, other insiders) 26-Apr-13 14,460,000 Direct

TAPIMMUNE INC
Beneficial Owner (10% or more)
Other OTC:TPIV
(historical quotes, other insiders) 9-Mar-15 5,000,000 Direct

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
9-Mar-15 5,607,143 CYCC Statement of Ownership
9-Mar-15 5,000,000 TPIV Statement of Ownership
25-Feb-14 500,000 CYTK Purchase at $8 per share.
(Cost of $4,000,000)
26-Apr-13 4,460,000 IBIO Purchase